Mengke Pharmaceutical (688373.SH): Application for New Drug Approval of Injection Kangtaizuo Amine Sodium Accepted for Review

Wisdom Financial APP news, Minkang Pharmaceutical (688373.SH) announced that recently, the company has received a "Notice of Acceptance" issued by the National Medical Products Administration. The New Drug Application (NDA) for the injection of kanamycin sodium submitted by the company has been accepted for review.